Summary:
Nontuberculous mycobacteria (NTM) are essentially ubiquitous and can infect both immunocompetent and immunocompromised hosts. However, NTM infection is surprisingly uncommon in reports from allogeneic hematopoietic stem cell transplant (alloSCT) centers that do not routinely perform allograft T-cell depletion. We reviewed medical records for all adult patients who underwent alloSCT at our center between January 1993 and December 2001. American Thoracic Society and Centers for Disease Control and Prevention guidelines Were used to define definite, probable, and possible NTM infection. Of 571 patients, 36 of 372 (9.7%) T-cell depleted and 14 of 199 (7.0%) conventional alloSCT recipients (P=0.26) had a positive culture for NTM after alloSCT. Of the 50 patients with NTM infection, 16 had definite infection and 34 had probable or possible infection. Rates of NTM infection were 5 to 20-fold higher than rates reported by other centers. Of the 16 definite infections, nine were caused by Mycobacterium haemophilum. Two patients had disseminated M. avium complex (MAC) infection and one had a vascular catheter infected by MAC. Three patients died from complications of NTM infection. Patients with probable or possible NTM infection had markedly different epidemiology, risk factors, site and species of NTM infection, and prognosis than patients with definite NTM infection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ozkaynak MF, Lenarsky C, Kohn D et al. Mycobacterium avium-intracellulare infections after allogeneic bone marrow transplantation in children. Am J Pediatr Hematol Oncol 1990; 12: 220.
Navari RM, Sullivan KM, Springmeyer SC et al. Mycobacterial infections in marrow transplant patients. Transplantation 1983; 36: 509–513.
White MH, Papadopoulos EB, Small TN et al. Mycobacterium haemophilum infections in bone marrow transplant recipients. Transplantation 1995; 60: 957–960.
Bekassy AN, Miorner H, Hagerstrand I, Anders F . Graft failure disclosing disseminated Mycobacterium avium-intracellulare infection. Bone Marrow Transplant 1992; 10: 476.
Martino R, Martinez C, Brunet S et al. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature. Bone Marrow Transplant 1996; 18: 809–812.
Shah MK, Sebti A, Kiehn TE et al. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis 2001; 33: 330–337.
Wallace RJ, Brown BA, Ohyi GO . Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticocorticosteoid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992; 166: 405–412.
Kurzrock R, Zander A, Vellekoop L et al. Mycobacerial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 1984; 77: 35–40.
Gaviria JM, Garcia PJ, Garrido SM et al. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. Biol Blood Marrow Transplant 2000; 6: 361.
Ward MS, Lam KV, Cannell PK, Herrmann RP . Mycobacterial central venous catheter tunnel infection: a difficult problem. Bone Marrow Transplant 1999; 24: 325–329.
Jacobson KL, Teira R, Libshitz HI et al. Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 2000; 31: 628–631.
Roy V, Weisdorf D . Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997; 19: 467–470.
IP MSM, Yuen KY, Woo PCY et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998; 158: 1173–1177.
George B, Matthews V, Srivastava V et al. Tuberculosis among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 2001; 27: 973–975.
Budak-Alpdogan T, Tangun Y, Kalayoglu-Besisik S et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant 2000; 6: 370–374.
Aljurf M, Gyger M, Alrajhi A et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant 1999; 24: 551–554.
Yuen KY, Woo PC, Liang RH et al. Clinical significance of alimentary tract microbes in bone marrow transplant recipients. Diagn Microbiol Infect Dis 1998; 30: 75–81.
Holland DJ, Chen SC, Chen WW, Gilbert GL . Mycobacterium neoaurum infection of a Hickman catheter in an immunosuppressed patient. Clin Infect Dis 1994; 18: 1002–1003.
Mohite U, Das M, Saikia T et al. Mycobacterial pulmonary infection post allogeneic bone marrow transplantation. Leukemia Lymphoma 2001; 40: 675–678.
Hermida G, Richard C, Baro J et al. Allogeneic BMT in a patient with CML and prior disseminated infection by Mycobacterium avium complex. Bone Marrow Transplant 1995; 16: 183–185.
Wallace RJ, Glassroth J, Griffith DE et al. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156: S1–S25.
Collins NH, Bleau SA, Kernan NA, O'Reilly RJ . T-cell depletion of bone marrow by treatment with soybean agglutinin and sheep red blood cell rosetting. In: Areman HJ, Deeg HJ, Sacher RA (eds) Bone Marrow and Stem Cell Processing: A Manual of Current Techniques. FA Davis: Philadelphia, PA, 1992, 171pp.
Kawanishi Y, Passweg J, Drobyski WR et al. Effect of T-cell subset dose on outcome of T-cell-depleted bone marrow transplantation. Bone Marrow Transplant 1997; 19: 1069–1077.
Horsburgh CR, Gettings J, Alexander LN, Lennox JL . Disseminated Mycobacterium avium complex disease among patients infected with Human Immunodeficiency Virus, 1985–2000. Clin Infect Dis 2001; 33: 1938–1943.
Hoyle C, Goldman JM . Life threatening infections occurring more than 3 months after BMT. Bone Marrow Transplant 1993; 14: 247–252.
Centers for Disease Control. Mycobacterium haemophilum infections—New York City metropolitan area, 1990–1991. MMWR 1991; 40: 636.
Rouleau M, Senik A, Leroy E, Vernant JP . Long-term persistence of transferred PPD-reactive T-cells after allogeneic bone marrow transplantation. Transplantation 1993; 55: 72–76.
Yuen KY, Woo PCY, Ip MSM et al. Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears. Clin Infect Dis 1997; 25: 37–42.
Jacobson MA, Hopewell PC, Yajko DM . Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 1991; 164: 994–998.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weinstock, D., Feinstein, M., Sepkowitz, K. et al. High rates of infection and colonization by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 31, 1015–1021 (2003). https://doi.org/10.1038/sj.bmt.1704043
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704043
Keywords
This article is cited by
-
Disseminated nontuberculous mycobacterial infections after allogeneic hematopoietic stem cell transplantation: a risk-based strategy for early diagnosis
Bone Marrow Transplantation (2023)
-
Non-Tuberculous Mycobacterial Infection in Hematopoietic Cell Transplant
Journal of Clinical Immunology (2020)
-
Cutaneous Mycobacterium haemophilum
Current Tropical Medicine Reports (2018)
-
Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients
International Journal of Hematology (2015)
-
Update on Nontuberculous Mycobacterial Infections in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
Current Infectious Disease Reports (2014)